Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to johnstevens77,Bhoddhisatva,scotia,Anonymous,Cornytiv34, for Donating to support the site

MrC's Smallcap Sweeps for Jun 2022

Discuss Stock buying Shares, tips and ideas for stock market dealing
Hallucigenia
Lemon Quarter
Posts: 2619
Joined: November 5th, 2016, 3:03 am
Has thanked: 166 times
Been thanked: 1718 times

Re: MrC's Smallcap Sweeps for Jun 2022

#511146

Postby Hallucigenia » July 1st, 2022, 12:39 pm

Just squeezing into June, the Lekoil results are some of the most fantastically bonkers I've ever seen, detailing the story of how their subsidiary in Nigeria went rogue and is refusing to pay back >£100m of intercompany loans, do read it :

https://www.investegate.co.uk/lekoil-li ... 54598789Q/

Pendrainllwyn
Lemon Slice
Posts: 304
Joined: November 4th, 2016, 9:53 pm
Has thanked: 162 times
Been thanked: 200 times

Re: MrC's Smallcap Sweeps for Jun 2022

#511239

Postby Pendrainllwyn » July 1st, 2022, 9:28 pm

Wow. Extraordinary naïveté.

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#511587

Postby MrContrarian » July 4th, 2022, 7:45 am

Smallcap Sweep. 04-Jul-22
Nanojam tomorrow

Inland Homes (INL) will get £19.2m in mid July from land and build sale of 85 units. [SP=31.5 Cap=71m]
Hipgnosis Songs Fund (SONG) welcomes the 44% uplift in the "all in" (mechanical and performance) statutory minimum rates for streaming paid in the US, rising from 10.5% of streaming revenues prior to 2018 to 15.1% in 2022. Follows disallow the appeal by various streaming services against the Copyright Royalty Board III determination. Hipgnosis has not accounted for any withheld revenue since 2020. [SP=108.62 Cap=1322m]
Omega Diagnostics (ODX) signs Heads of Terms with a buyer to acquire its CD4 business. Undisclosed 'significant' sum plus royalties. "Having withdrawn from the COVID-19 market and disposed of the Alva site earlier this year, the divestment of our loss-making CD4 business will leave the Group solely focused on our higher margin Health & Nutrition division." [SP=3.06 Cap=7m]
H&T (HAT) H1(June) trading: retail sales in line, pledge book £84.2m (£48.3m), FX rev more than doubled . [SP=325.64 Cap=130m]
Palace Capital (PCA) outcome of the strategic review: will become an ESG driven regional office specialist following the proposed sale of its industrial portfolio, recently valued at £46.5m. Co wil return cash if it doesn't find not find suitable acquisitions. Will buyback up to 5% of shares. Will look at cutting admin cost. [SP=266.02 Cap=123m]
nanosynth (NNN) Further Strategic Update. "The business is now ten months into its turnaround strategy following the appointment of Mark Duffin as CEO in Sept 2021, and whilst the Company understands and appreciates shareholders' frustration at the speed of progress and irregular newsflow, the Group would like to emphasise that good momentum is being gained and updates are being provided to shareholders when appropriate." Nanojam tomorrow. [SP=0.25 Cap=5m]
WANdisco (WAND) $5m+ 5 yr contract with a global automotive supplier. 50% in advance. [SP=290 Cap=192m]

In line: BBB
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#511751

Postby MrContrarian » July 5th, 2022, 7:52 am

Smallcap Sweep. 05-Jul-22
Thirst quarter

Young & Co's Brewery (YNGA) first quarter rev up 40% and 35% organic. Strong balance sheet make it "well-placed to make further investments". [SP=1120 Cap=562m]
Synectics (SNX) FD scarpers. He is not thanked. [SP=103.5 Cap=18m]
DX (DX.) re corporate governance inquiry - board will undertake some further work to be completed by end Sept. Shares remain suspended. [SP=30 Cap=172m]
DFS (DFS) guides FY U/L pretax profitability to be in the upper half of the guided range. [SP=153 Cap=390m]
Saga (SAGA) AGM stmt - guides FY23 in line. Motor and home insurance sales 9% down due to decline in new business; aims to return to growth in 2023/24 with av margin c. £60 (£73) per policy. "Strong launch of 2023/24 Cruise season with bookings representing a load factor of 34% and per diem of £312, both well ahead of expectations." [SP=166.9 Cap=234m]
Totally (TLY) wins £19m contract extensions to run until January 2023. [SP=45.32 Cap=85m]
Gresham Technologies (GHT) guides FY(Dec) in line and FY23 rev and adj EBITDA at least in line with market expectations. Gives consensus figures. [SP=139 Cap=118m]
Equals (EQLS) guides FY(Dec) adj EBITDA ahead of current market expectations. H1 rev up 84% and gross profit up 47%. [SP=78.5 Cap=141m]
Pressure Technologies (PRES) sale and leaseback brings in £1.65m. [SP=63.95 Cap=20m]
Cizzle Biotechnology (CIZ) progress update and "a new project that may extend the range of early-stage cancers that its technology can detect". [SP=1.35 Cap=4m]
Cordel (CRDL) 1 yr contract to deliver its LiDAR-based solutions to One Rail Australia. No £££ [SP=4 Cap=7m]
Glantus (GLAN) contract from Bunzl for recovery audit and an automated statement reconciliation solution. No £££. [SP=50.95 Cap=19m]

In line: TRT, SMRT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#512047

Postby MrContrarian » July 6th, 2022, 7:40 am

Smallcap Sweep. 06-Jul-22
Leaning on meaning

SEEEN (SEEN) two new customers for CreatorSuite. No £££. [SP=13.01 Cap=6m]
C4X Discovery (C4XD) gets €3m milestone payment triggered by pre-clinical progression in oral IL-17A inhibitor programme. [SP=21 Cap=48m]
AO World (AO.) £40m placing + PrimaryBid offer at 43p, an 8% discount. Trading in line. [SP=46.64 Cap=224m]
GETECH (GTC) wins $2.15m of new contracts. C. 56% will be booked in FY22. [SP=18.94 Cap=13m]
Surface Transforms (SCE) restates guidance of a profit in FY22. "The small delay in OEM 8 start of production is offset by higher than forecast development revenues with other customers." [SP=43.2 Cap=84m]
Inland Homes (INL) sells land for £12.7m. £9.5m will repay debt. [SP=29.5 Cap=67m]
ATTRAQT (ATQT) guides H1(June) rev up 8% at const FX, in line with management's expectations. "Alongside well-publicised macro-economic conditions, we expect the deteriorating outlook for consumer facing businesses to delay some customer decisions and as flagged in the full year results update, for lead times on enterprise sales to lengthen." [SP=24.01 Cap=50m]
WANdisco (WAND) gets $1.1m contract over three years. First Google Cloud win in North America. [SP=298.37 Cap=198m]
Cerillion (CER) £15m ten yr contract. Implementation starts immediately. [SP=928 Cap=274m]
Real Estate Investors (RLE) H1 trading: sold £5.7m of assets at 28% above book (at Dec 2021). "If the significant share price discount to NTA persists, we will consider a special dividend, share buyback or other form of capital return to shareholders." [SP=34.85 Cap=63m]
Robert Walters (RWA) guides FY(Dec) slightly ahead of market expectations. Q2 net fee income up 25%. [SP=502 Cap=386m]
Ten Entertainment (TEG) guides FY(Dec) rev above expectations (whose?). H1 rev up 53% on 2019. [SP=215 Cap=147m]
ECSC (ECSC) wins £590k on contracts, over 3 yrs. Order book up 30% YoY. [SP=39.4 Cap=4m]

In line: TPT, NUM
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#512365

Postby MrContrarian » July 7th, 2022, 7:39 am

Smallcap Sweep. 07-Jul-22
Eight'o'clock Crock

Novacyt (NCYT) guides H1(June) rev down 68%. Covid revs down 73%, worse than expected. "If the rate of COVID-19 sales decline experienced in Q2 2022 continues for the remainder of 2022, the Board expects full year revenues of circa £25m." Was £35-45m. [SP=148.7 Cap=123m]
Mattioli Woods (MTW) guides FY(May) rev up 70% (10% organic) and profit in line with management's expectations. Consensus rev £107.4m, adj EBITDA £32.8m and adj pretax £29.8m. Current trading ahead of mgmt expectations but inflation will hit margins. [SP=702.82 Cap=359m]
Peel Hunt (PEEL) Q1 rev £22.8m. No YoY change given. Blames continuing low levels of market wide capital markets activity. [SP=113.9 Cap=140m]
Symphony Environmental Technologies (SYM) $340k orders for d2p AI (anti-insect technology). [SP=17.6 Cap=32m]
Time Finance (TIME) guides FY(May) own-book gross lending portfolio up 19%. TNAV up 7%. Pretax £1.1m down 45% due to "goodwill write-off of a non-core brokerage and restructuring costs in streamlining the business". "The results, while satisfactory, reflect the organic growth we anticipated in relation to the commercial own-book lending but are impacted by the continued underperformance of the non-core consumer brokerages and wider macro-economic headwinds." [SP=18.5 Cap=17m]
Sabien Technology (SNT) guides FY(June) rev £0.83m down 14% but H2 was up 25%. "During the year under review, despite a challenging supply chain environment, the Company has achieved a solid result for the M2G business once supply chain timing issues are resolved, in addition much development of the COF/b.grn business has been achieved and a fundable business model developed." [SP=19.33 Cap=3m]
Deltex Medical (DEMG) guides H1(June) rev up 9%. "We are pleased to see a return to growth in the first half. It is encouraging to see our international division continue to grow strongly and we expect growth to return in the UK and USA markets as Covid-related restrictions continue to ease." [SP=1.1 Cap=8m]
DX (DX.) guides FY(July) rev up 11%, significantly ahead of management targets. Net cash £27m up 61%. [SP=30 Cap=172m]

In line: CPX, BIDS, PYC, MBH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#512640

Postby MrContrarian » July 8th, 2022, 7:37 am

Smallcap Sweep. 08-Jul-22
The safety bar on the City big dipper

Oncimmune (ONC) trading: slowdown in signing new ImmunoINSIGHTS contracts. Blames "global economic and geopolitical conditions have well reported as adversely affecting the biotech sector". Chmn change. [SP=80.38 Cap=56m]
Northern Bear (NTBR) settles £1.9m claim from Engie Regeneration for £0.6m. Co said it would "will vigorously defend the claim" and made no provision. [SP=58.7 Cap=11m]
Science in Sport (SIS) guides H1(June) up 12% and expects better in H2. However sees £3.2m of costs or margin loss for the year compared to budget. Blames "raw material price increases, fuel and logistics costs, people retention costs, and closure of our Russian business". [SP=45.5 Cap=63m]
Chamberlin (CMH) guides FY(May) rev £16.5m and pretax £0.1m, both in line with mkt exp. Has higher than expected levels of orders for Q1 and strong order book. [SP=4.61 Cap=5m]
Litigation Capital Management (LIT) guides FY(June) gross rev up 25% and adj op profit up 15%. "The Company had two material investments move into future financial periods. Whilst such delays are diminishing, they are still present in our portfolio. The financial performance of those investments will not be adversely impacted by the delay indeed it may be enhanced." No guidance for FY23. [SP=92.4 Cap=110m]
Live Company (LVCG) £0.6m placing and £0.4m broker option at 4p, a 13% discount, for working capital, and related-party acquisition. [SP=4.6 Cap=8m]
Iofina (IOF) $4.4m loans for capex. H1 production in line. [SP=26.2 Cap=51m]
Tekmar (TGP) wins 'significant' new contract to be delivered in 2023. No £££. [SP=6.2 Cap=4m]
Osirium Technologies (OSI) guides H1(June) rev £0.91m up 23% and bookings up 30%. Confident of meeting FY revenue and bookings guidance. Reminds us that it will be required to raise additional capital in H2. [SP=6 Cap=3m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#513347

Postby MrContrarian » July 11th, 2022, 7:48 am

Smallcap Sweep. 11-Jul-22
Breaking legs to fit the sarcophagus of news

Mpac (MPAC) guides FY(Dec) rev in line but profit significantly below mkt expectations due to supply chain delays and inflation. [SP=379 Cap=77m]
SEEEN (SEEN) sells CreatorSuite licence to the Daily Mail, the first example of SEEEN integrating its CreatorSuite offering with a separate video player. No £££. [SP=11 Cap=6m]
Omega Diagnostics (ODX) gets long due payment from Abingdon Health after latter gets payment from the DHSC. [SP=3.26 Cap=8m]
Woodbois (WBI) guides H2 rev up 38% and margin 23% (20%). "Whilst there are many challenges ahead, the next step in our journey to scale the business is the full commissioning of our second veneer line in Mouila, Gabon, which we expect to contribute to a further increase in revenues, margins and profitability." [SP=5.48 Cap=114m]
7digital (7DIG) wins 2 yr music-as-a-service contract from with Singapore-based Lomotif, one of the top worldwide social video-sharing apps. No £££. [SP=0.17 Cap=5m]
Dekel Agri-Vision (DKL) H1(June) "remained strong with increased gross margin percentage largely offsetting lower volumes...Palm Oil Operation is well-positioned to deliver a sustained period of operating profitability". [SP=3.2 Cap=17m]
MJ Gleeson (GLE) guides FY(June) significantly ahead of expectations with units sold up 10% and strong selling price increases offset significant material and labour cost increases. [SP=514 Cap=300m]
BATM Advanced Communications (BVC) CityFibre has selected BATM's Edgility virtual networking and edge compute solution. "Will be piloting the Edgility platform with selected partners ahead of an expected national deployment to provide virtualised network services for businesses." [SP=34.9 Cap=154m]
Oxford Nanopore Technologies (ONT) sale and leaseback of HQ for for £42.5m. Rent will be £1.8m PA. [SP=321 Cap=2644m]
Joules (JOUL) re Sunday Times article. Confirms it has appointed KPMG debt advisory to assist in "improving profitability, cash generation and liquidity headroom". "Whilst the Group continues to manage its cash resources carefully over its seasonal borrowing peak, it expects to have sufficient liquidity to manage its working capital requirements over this time." [SP=33.35 Cap=37m]
SpaceandPeople (SAL) guides FY(Dec) rev £5.5m+ assuming no further pandemic induced lock downs. H1 rev £2.5m (£1.1m). [SP=95 Cap=2m]
Kinovo (KINO) update on trading and developments relating to DCB, its former subsidiary. "Kinovo is also the largest creditor of DCB and at this stage, Kinovo's expectation is that there will be limited recovery of the amounts owed." Also Kinovo continues to facilitate constructive discussions with HSBC regarding the refinancing of its existing facilities. [SP=16 Cap=10m]
WANdisco (WAND) H1 bookings up 1,200% to $27.3m. Outlook confident. [SP=292 Cap=193m]
Induction Healthcare (INHC) System C Healthcare to distribute Induction Zesty product in the UK. [SP=47 Cap=44m]
Norman Broadbent (NBB) guides H1(June) net fee income up 20%. EBITDA £40k to £60k. In line? [SP=6.18 Cap=4m]

In line: CSFS, DFCH, MORE, BYOT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#513597

Postby MrContrarian » July 12th, 2022, 7:34 am

Smallcap Sweep. 12-Jul-22
Beakneck blatherings

Sanderson Design (SDG) AGM stmt: rev YTD broadly in line with last year and FY profits remain on track to mgmt expectations. [SP=122 Cap=87m]
System1 (SYS1) FY(Mar). Recent Q1 rev down 20%. Rev and profit broadly in line with mgmt expectations "and reflected inflationary pressures, tighter marketing budgets for some customers and continued softness in bespoke consultancy revenues, particularly in the USA". If marketing budgets are reduced "revenues and profits for remainder of the year would be adversely affected". [SP=290 Cap=37m]
MJ Hudson (MJH) guides FY(June) modestly ahead of May's guidance. [SP=34.7 Cap=60m]
Hostelworld (HSW) June 2022 rev up 4% on 2019 with net bookings down 20%. "Overall, we are seeing the recovery continue across all destinations and demand segments." [SP=92 Cap=108m]
tinyBuild (TBLD) guides H1(June) slightly ahead of expectations and FY at least in line. [SP=120 Cap=244m]
Restaurant Group (RTN) buys Barburrito Mexican fast-casual restaurant chain for £7m or 4.4x EBITDA. RTN repaid a further £44m of its term loan and has bought interest rate caps. [SP=44.2 Cap=338m]
Destiny Pharma (DEST) gets grant from the Cystic Fibrosis Foundation. No £££. [SP=37.5 Cap=27m]
Synectics (SNX) H1(May) rev up 4% and pretax £0.5m (-£0.8m). Expects further improved results in the seasonally stronger H2. [SP=95 Cap=17m]
OTAQ (OTAQ) appointed as the technology supplier to a Chilean salmon & sea trout producer for integrated water quality measurement equipment to several cultivation sites. No £££. [SP=13.25 Cap=5m]

In line: WIN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jun 2022

#514198

Postby MrContrarian » July 14th, 2022, 7:50 am

Smallcap Sweep. 14-Jul-22
Charity shop of unwanted tat

Circassia (CIR) guides H1(June) U/L rev up 11% and adj EBITDA £3.2m (-£0.3m). "Believes that EBITDA for 2022 will, in the absence of any fresh lockdown restrictions in major markets, be significantly ahead of our May expectations.." [SP=32 Cap=134m]
Portmeirion (PMP) guides H1(June) rev up 5%. Outlook cautious. Has seen "retail customers react to the economic environment by de-stocking in the first half and we remain cautious to the risk of further declines in consumer and retailer confidence for our key second half trading period." [SP=416.8 Cap=58m]
Galliford Try (GRFD) guides FY(June) pre-exceptional pretax at the upper end of forecasts of £16.4m to £18m. Confident outlook. [SP=NA Cap=NA]
Quixant (QXT) guides FY(Dec) revenue and profit to be ahead of market expectations of $95.5m and $95.8m and adjusted pretax of $7.8m. [SP=153.5 Cap=103m]
Hardide (HDD) guides FY(Sep) rev "broadly in line with the Board's expectations albeit with a slightly wider range of possible outcomes, which will also be reflected at the EBITDA level...As previously stated, the Group is exploring financing options to support its near-term working capital requirements in addition to potential investment in equipment." [SP=23.08 Cap=13m]
Finncap (FCAP) FY(Mar). Guides FY23 revenue and financial performance to be substantially below FY22. [SP=18.5 Cap=33m]

In line: TM17, XAR, TRST, MCB, IQE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 7 guests